WHO ICTRP trial

Comparison of three commonly used drugs: Dexmedetomidine, Clonidine, and…

CTRI/2022/10/046459 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2022/10/046459
Public title Comparison of three commonly used drugs: Dexmedetomidine, Clonidine, and Magnesium Sulphate to find the best drug in reducing blood pressure, blood loss and improved surgical outcome during Sinus Surgery.
Scientific title Comparison of Dexmedetomidine, Clonidine and Magnesium Sulphate for induced hypotension during functional endoscopic sinus surgery: A randomized control trial
Primary sponsor Dr Akshatha G Kamath
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Countries India
Conditions Health Condition 1: O- Medical and Surgical Health Condition 2: J348- Other specified disorders of noseand nasal sinuses
Interventions Intervention1: Injection Dexmedetomidine: Injection Dexmedetomidine iv 0.75 Ã?µg/kg in 50 ml of saline over 20 minutes followed by 0.3-0.5 Ã?µg/kg/hour infusion. Control Intervention1: injection Clonidine: Injection clonidine iv 1.5…
Registration date Oct 13, 2022
Target size 114
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations